Brian Kim

Mission Bio, Inc. engages in the provision of tools for the study of cellular heterogeneity in human health and life science research. It develops research tools that allow high-throughput, single-cell nucleic acid characterization across a variety of research applications, including oncology and immunology. The company was founded by Charlie Silver, Adam Sciambi, Adam Abate, and Dennis Eastburn on June 29, 2011 and is headquartered in San Francisco, CA.

Mission Bio, Inc. engages in the provision of tools for the study of cellular heterogeneity in human health and life science research. It develops research tools that allow high-throughput, single-cell nucleic acid characterization across a variety of research applications, including oncology and immunology. The company was founded by Charlie Silver, Adam Sciambi, Adam Abate, and Dennis Eastburn on June 29, 2011 and is headquartered in San Francisco, CA.

Mission Bio, Inc. engages in the provision of tools for the study of cellular heterogeneity in human health and life science research. It develops research tools that allow high-throughput, single-cell nucleic acid characterization across a variety of research applications, including oncology and immunology. The company was founded by Charlie Silver, Adam Sciambi, Adam Abate, and Dennis Eastburn on June 29, 2011 and is headquartered in San Francisco, CA.

Mission Bio, Inc. engages in the provision of tools for the study of cellular heterogeneity in human health and life science research. It develops research tools that allow high-throughput, single-cell nucleic acid characterization across a variety of research applications, including oncology and immunology. The company was founded by Charlie Silver, Adam Sciambi, Adam Abate, and Dennis Eastburn on June 29, 2011 and is headquartered in San Francisco, CA.

Mission Bio, Inc. engages in the provision of tools for the study of cellular heterogeneity in human health and life science research. It develops research tools that allow high-throughput, single-cell nucleic acid characterization across a variety of research applications, including oncology and immunology. The company was founded by Charlie Silver, Adam Sciambi, Adam Abate, and Dennis Eastburn on June 29, 2011 and is headquartered in San Francisco, CA.

Fortis Life Sciences LLC is an American life sciences company that was established in 2020 with a mission to offer world-class products and customer experience. The company is based in the United States and has subsidiaries in Canada and the United States. The company has built a portfolio of high-quality products and brands serving various life sciences end markets, including diagnostic, therapeutic, and research. Fortis Life Sciences offers word-class reagents, tools, materials, and custom services for their research, diagnostic, and therapeutic customers. The company was founded in 2020 by Brian S. Kim and Ken Yoon, with Brian S. Kim serving as the CEO since then.

Mission Bio, Inc. engages in the provision of tools for the study of cellular heterogeneity in human health and life science research. It develops research tools that allow high-throughput, single-cell nucleic acid characterization across a variety of research applications, including oncology and immunology. The company was founded by Charlie Silver, Adam Sciambi, Adam Abate, and Dennis Eastburn on June 29, 2011 and is headquartered in San Francisco, CA.

Fortis Life Sciences LLC is an American life sciences company that was established in 2020 with a mission to offer world-class products and customer experience. The company is based in the United States and has subsidiaries in Canada and the United States. The company has built a portfolio of high-quality products and brands serving various life sciences end markets, including diagnostic, therapeutic, and research. Fortis Life Sciences offers word-class reagents, tools, materials, and custom services for their research, diagnostic, and therapeutic customers. The company was founded in 2020 by Brian S. Kim and Ken Yoon, with Brian S. Kim serving as the CEO since then.